Global Neurological Disease Model Chip Market Research Report 2026(Status and Outlook)
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
The global Neurological Disease Model Chip market size was estimated at USD 54.8 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neurological Disease Model Chip market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neurological Disease Model Chip market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurological Disease Model Chip market.
Global Neurological Disease Model Chip Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Market Segmentation (by Type)
Neuron Chip
Brain Chip
Brain Organ Chip
Market Segmentation (by Application)
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurological Disease Model Chip Market
Overview of the regional outlook of the Neurological Disease Model Chip Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Disease Model Chip Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neurological Disease Model Chip, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Neurological Disease Model Chip market size was estimated at USD 54.8 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neurological Disease Model Chip market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neurological Disease Model Chip market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurological Disease Model Chip market.
Global Neurological Disease Model Chip Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Market Segmentation (by Type)
Neuron Chip
Brain Chip
Brain Organ Chip
Market Segmentation (by Application)
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurological Disease Model Chip Market
Overview of the regional outlook of the Neurological Disease Model Chip Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Disease Model Chip Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neurological Disease Model Chip, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neurological Disease Model Chip
1.2 Key Market Segments
1.2.1 Neurological Disease Model Chip Segment by Type
1.2.2 Neurological Disease Model Chip Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGICAL DISEASE MODEL CHIP MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurological Disease Model Chip Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Neurological Disease Model Chip Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGICAL DISEASE MODEL CHIP MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neurological Disease Model Chip Product Life Cycle
3.3 Global Neurological Disease Model Chip Sales by Manufacturers (2020-2025)
3.4 Global Neurological Disease Model Chip Revenue Market Share by Manufacturers (2020-2025)
3.5 Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neurological Disease Model Chip Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neurological Disease Model Chip Market Competitive Situation and Trends
3.8.1 Neurological Disease Model Chip Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neurological Disease Model Chip Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEUROLOGICAL DISEASE MODEL CHIP INDUSTRY CHAIN ANALYSIS
4.1 Neurological Disease Model Chip Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGICAL DISEASE MODEL CHIP MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neurological Disease Model Chip Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neurological Disease Model Chip Market
5.7 ESG Ratings of Leading Companies
6 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Disease Model Chip Sales Market Share by Type (2020-2025)
6.3 Global Neurological Disease Model Chip Market Size by Type (2020-2025)
6.4 Global Neurological Disease Model Chip Price by Type (2020-2025)
7 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Disease Model Chip Market Sales by Application (2020-2025)
7.3 Global Neurological Disease Model Chip Market Size (M USD) by Application (2020-2025)
7.4 Global Neurological Disease Model Chip Sales Growth Rate by Application (2020-2025)
8 NEUROLOGICAL DISEASE MODEL CHIP MARKET SALES BY REGION
8.1 Global Neurological Disease Model Chip Sales by Region
8.1.1 Global Neurological Disease Model Chip Sales by Region
8.1.2 Global Neurological Disease Model Chip Sales Market Share by Region
8.2 Global Neurological Disease Model Chip Market Size by Region
8.2.1 Global Neurological Disease Model Chip Market Size by Region
8.2.2 Global Neurological Disease Model Chip Market Size by Region
8.3 North America
8.3.1 North America Neurological Disease Model Chip Sales by Country
8.3.2 North America Neurological Disease Model Chip Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neurological Disease Model Chip Sales by Country
8.4.2 Europe Neurological Disease Model Chip Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neurological Disease Model Chip Sales by Region
8.5.2 Asia Pacific Neurological Disease Model Chip Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neurological Disease Model Chip Sales by Country
8.6.2 South America Neurological Disease Model Chip Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neurological Disease Model Chip Sales by Region
8.7.2 Middle East and Africa Neurological Disease Model Chip Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEUROLOGICAL DISEASE MODEL CHIP MARKET PRODUCTION BY REGION
9.1 Global Production of Neurological Disease Model Chip by Region(2020-2025)
9.2 Global Neurological Disease Model Chip Revenue Market Share by Region (2020-2025)
9.3 Global Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neurological Disease Model Chip Production
9.4.1 North America Neurological Disease Model Chip Production Growth Rate (2020-2025)
9.4.2 North America Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neurological Disease Model Chip Production
9.5.1 Europe Neurological Disease Model Chip Production Growth Rate (2020-2025)
9.5.2 Europe Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neurological Disease Model Chip Production (2020-2025)
9.6.1 Japan Neurological Disease Model Chip Production Growth Rate (2020-2025)
9.6.2 Japan Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neurological Disease Model Chip Production (2020-2025)
9.7.1 China Neurological Disease Model Chip Production Growth Rate (2020-2025)
9.7.2 China Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Emulate
10.1.1 Emulate Basic Information
10.1.2 Emulate Neurological Disease Model Chip Product Overview
10.1.3 Emulate Neurological Disease Model Chip Product Market Performance
10.1.4 Emulate Business Overview
10.1.5 Emulate SWOT Analysis
10.1.6 Emulate Recent Developments
10.2 CN Bio
10.2.1 CN Bio Basic Information
10.2.2 CN Bio Neurological Disease Model Chip Product Overview
10.2.3 CN Bio Neurological Disease Model Chip Product Market Performance
10.2.4 CN Bio Business Overview
10.2.5 CN Bio SWOT Analysis
10.2.6 CN Bio Recent Developments
10.3 TissUse
10.3.1 TissUse Basic Information
10.3.2 TissUse Neurological Disease Model Chip Product Overview
10.3.3 TissUse Neurological Disease Model Chip Product Market Performance
10.3.4 TissUse Business Overview
10.3.5 TissUse SWOT Analysis
10.3.6 TissUse Recent Developments
10.4 AxoSim Technologies
10.4.1 AxoSim Technologies Basic Information
10.4.2 AxoSim Technologies Neurological Disease Model Chip Product Overview
10.4.3 AxoSim Technologies Neurological Disease Model Chip Product Market Performance
10.4.4 AxoSim Technologies Business Overview
10.4.5 AxoSim Technologies Recent Developments
10.5 Nortis
10.5.1 Nortis Basic Information
10.5.2 Nortis Neurological Disease Model Chip Product Overview
10.5.3 Nortis Neurological Disease Model Chip Product Market Performance
10.5.4 Nortis Business Overview
10.5.5 Nortis Recent Developments
10.6 Mimetas
10.6.1 Mimetas Basic Information
10.6.2 Mimetas Neurological Disease Model Chip Product Overview
10.6.3 Mimetas Neurological Disease Model Chip Product Market Performance
10.6.4 Mimetas Business Overview
10.6.5 Mimetas Recent Developments
10.7 SynVivo
10.7.1 SynVivo Basic Information
10.7.2 SynVivo Neurological Disease Model Chip Product Overview
10.7.3 SynVivo Neurological Disease Model Chip Product Market Performance
10.7.4 SynVivo Business Overview
10.7.5 SynVivo Recent Developments
10.8 Axion Biosystems
10.8.1 Axion Biosystems Basic Information
10.8.2 Axion Biosystems Neurological Disease Model Chip Product Overview
10.8.3 Axion Biosystems Neurological Disease Model Chip Product Market Performance
10.8.4 Axion Biosystems Business Overview
10.8.5 Axion Biosystems Recent Developments
10.9 Tara Biosystems
10.9.1 Tara Biosystems Basic Information
10.9.2 Tara Biosystems Neurological Disease Model Chip Product Overview
10.9.3 Tara Biosystems Neurological Disease Model Chip Product Market Performance
10.9.4 Tara Biosystems Business Overview
10.9.5 Tara Biosystems Recent Developments
10.10 InSphero
10.10.1 InSphero Basic Information
10.10.2 InSphero Neurological Disease Model Chip Product Overview
10.10.3 InSphero Neurological Disease Model Chip Product Market Performance
10.10.4 InSphero Business Overview
10.10.5 InSphero Recent Developments
10.11 Hesperos
10.11.1 Hesperos Basic Information
10.11.2 Hesperos Neurological Disease Model Chip Product Overview
10.11.3 Hesperos Neurological Disease Model Chip Product Market Performance
10.11.4 Hesperos Business Overview
10.11.5 Hesperos Recent Developments
10.12 Kugelmeiers
10.12.1 Kugelmeiers Basic Information
10.12.2 Kugelmeiers Neurological Disease Model Chip Product Overview
10.12.3 Kugelmeiers Neurological Disease Model Chip Product Market Performance
10.12.4 Kugelmeiers Business Overview
10.12.5 Kugelmeiers Recent Developments
10.13 Ascendance Biotechnology
10.13.1 Ascendance Biotechnology Basic Information
10.13.2 Ascendance Biotechnology Neurological Disease Model Chip Product Overview
10.13.3 Ascendance Biotechnology Neurological Disease Model Chip Product Market Performance
10.13.4 Ascendance Biotechnology Business Overview
10.13.5 Ascendance Biotechnology Recent Developments
10.14 BioIVT
10.14.1 BioIVT Basic Information
10.14.2 BioIVT Neurological Disease Model Chip Product Overview
10.14.3 BioIVT Neurological Disease Model Chip Product Market Performance
10.14.4 BioIVT Business Overview
10.14.5 BioIVT Recent Developments
10.15 BGI Genomics
10.15.1 BGI Genomics Basic Information
10.15.2 BGI Genomics Neurological Disease Model Chip Product Overview
10.15.3 BGI Genomics Neurological Disease Model Chip Product Market Performance
10.15.4 BGI Genomics Business Overview
10.15.5 BGI Genomics Recent Developments
11 NEUROLOGICAL DISEASE MODEL CHIP MARKET FORECAST BY REGION
11.1 Global Neurological Disease Model Chip Market Size Forecast
11.2 Global Neurological Disease Model Chip Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neurological Disease Model Chip Market Size Forecast by Country
11.2.3 Asia Pacific Neurological Disease Model Chip Market Size Forecast by Region
11.2.4 South America Neurological Disease Model Chip Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neurological Disease Model Chip by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Neurological Disease Model Chip Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Neurological Disease Model Chip by Type (2026-2035)
12.1.2 Global Neurological Disease Model Chip Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Neurological Disease Model Chip by Type (2026-2035)
12.2 Global Neurological Disease Model Chip Market Forecast by Application (2026-2035)
12.2.1 Global Neurological Disease Model Chip Sales (K Units) Forecast by Application
12.2.2 Global Neurological Disease Model Chip Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neurological Disease Model Chip
1.2 Key Market Segments
1.2.1 Neurological Disease Model Chip Segment by Type
1.2.2 Neurological Disease Model Chip Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGICAL DISEASE MODEL CHIP MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurological Disease Model Chip Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Neurological Disease Model Chip Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGICAL DISEASE MODEL CHIP MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neurological Disease Model Chip Product Life Cycle
3.3 Global Neurological Disease Model Chip Sales by Manufacturers (2020-2025)
3.4 Global Neurological Disease Model Chip Revenue Market Share by Manufacturers (2020-2025)
3.5 Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neurological Disease Model Chip Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neurological Disease Model Chip Market Competitive Situation and Trends
3.8.1 Neurological Disease Model Chip Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neurological Disease Model Chip Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEUROLOGICAL DISEASE MODEL CHIP INDUSTRY CHAIN ANALYSIS
4.1 Neurological Disease Model Chip Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGICAL DISEASE MODEL CHIP MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neurological Disease Model Chip Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neurological Disease Model Chip Market
5.7 ESG Ratings of Leading Companies
6 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Disease Model Chip Sales Market Share by Type (2020-2025)
6.3 Global Neurological Disease Model Chip Market Size by Type (2020-2025)
6.4 Global Neurological Disease Model Chip Price by Type (2020-2025)
7 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Disease Model Chip Market Sales by Application (2020-2025)
7.3 Global Neurological Disease Model Chip Market Size (M USD) by Application (2020-2025)
7.4 Global Neurological Disease Model Chip Sales Growth Rate by Application (2020-2025)
8 NEUROLOGICAL DISEASE MODEL CHIP MARKET SALES BY REGION
8.1 Global Neurological Disease Model Chip Sales by Region
8.1.1 Global Neurological Disease Model Chip Sales by Region
8.1.2 Global Neurological Disease Model Chip Sales Market Share by Region
8.2 Global Neurological Disease Model Chip Market Size by Region
8.2.1 Global Neurological Disease Model Chip Market Size by Region
8.2.2 Global Neurological Disease Model Chip Market Size by Region
8.3 North America
8.3.1 North America Neurological Disease Model Chip Sales by Country
8.3.2 North America Neurological Disease Model Chip Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neurological Disease Model Chip Sales by Country
8.4.2 Europe Neurological Disease Model Chip Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neurological Disease Model Chip Sales by Region
8.5.2 Asia Pacific Neurological Disease Model Chip Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neurological Disease Model Chip Sales by Country
8.6.2 South America Neurological Disease Model Chip Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neurological Disease Model Chip Sales by Region
8.7.2 Middle East and Africa Neurological Disease Model Chip Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEUROLOGICAL DISEASE MODEL CHIP MARKET PRODUCTION BY REGION
9.1 Global Production of Neurological Disease Model Chip by Region(2020-2025)
9.2 Global Neurological Disease Model Chip Revenue Market Share by Region (2020-2025)
9.3 Global Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neurological Disease Model Chip Production
9.4.1 North America Neurological Disease Model Chip Production Growth Rate (2020-2025)
9.4.2 North America Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neurological Disease Model Chip Production
9.5.1 Europe Neurological Disease Model Chip Production Growth Rate (2020-2025)
9.5.2 Europe Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neurological Disease Model Chip Production (2020-2025)
9.6.1 Japan Neurological Disease Model Chip Production Growth Rate (2020-2025)
9.6.2 Japan Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neurological Disease Model Chip Production (2020-2025)
9.7.1 China Neurological Disease Model Chip Production Growth Rate (2020-2025)
9.7.2 China Neurological Disease Model Chip Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Emulate
10.1.1 Emulate Basic Information
10.1.2 Emulate Neurological Disease Model Chip Product Overview
10.1.3 Emulate Neurological Disease Model Chip Product Market Performance
10.1.4 Emulate Business Overview
10.1.5 Emulate SWOT Analysis
10.1.6 Emulate Recent Developments
10.2 CN Bio
10.2.1 CN Bio Basic Information
10.2.2 CN Bio Neurological Disease Model Chip Product Overview
10.2.3 CN Bio Neurological Disease Model Chip Product Market Performance
10.2.4 CN Bio Business Overview
10.2.5 CN Bio SWOT Analysis
10.2.6 CN Bio Recent Developments
10.3 TissUse
10.3.1 TissUse Basic Information
10.3.2 TissUse Neurological Disease Model Chip Product Overview
10.3.3 TissUse Neurological Disease Model Chip Product Market Performance
10.3.4 TissUse Business Overview
10.3.5 TissUse SWOT Analysis
10.3.6 TissUse Recent Developments
10.4 AxoSim Technologies
10.4.1 AxoSim Technologies Basic Information
10.4.2 AxoSim Technologies Neurological Disease Model Chip Product Overview
10.4.3 AxoSim Technologies Neurological Disease Model Chip Product Market Performance
10.4.4 AxoSim Technologies Business Overview
10.4.5 AxoSim Technologies Recent Developments
10.5 Nortis
10.5.1 Nortis Basic Information
10.5.2 Nortis Neurological Disease Model Chip Product Overview
10.5.3 Nortis Neurological Disease Model Chip Product Market Performance
10.5.4 Nortis Business Overview
10.5.5 Nortis Recent Developments
10.6 Mimetas
10.6.1 Mimetas Basic Information
10.6.2 Mimetas Neurological Disease Model Chip Product Overview
10.6.3 Mimetas Neurological Disease Model Chip Product Market Performance
10.6.4 Mimetas Business Overview
10.6.5 Mimetas Recent Developments
10.7 SynVivo
10.7.1 SynVivo Basic Information
10.7.2 SynVivo Neurological Disease Model Chip Product Overview
10.7.3 SynVivo Neurological Disease Model Chip Product Market Performance
10.7.4 SynVivo Business Overview
10.7.5 SynVivo Recent Developments
10.8 Axion Biosystems
10.8.1 Axion Biosystems Basic Information
10.8.2 Axion Biosystems Neurological Disease Model Chip Product Overview
10.8.3 Axion Biosystems Neurological Disease Model Chip Product Market Performance
10.8.4 Axion Biosystems Business Overview
10.8.5 Axion Biosystems Recent Developments
10.9 Tara Biosystems
10.9.1 Tara Biosystems Basic Information
10.9.2 Tara Biosystems Neurological Disease Model Chip Product Overview
10.9.3 Tara Biosystems Neurological Disease Model Chip Product Market Performance
10.9.4 Tara Biosystems Business Overview
10.9.5 Tara Biosystems Recent Developments
10.10 InSphero
10.10.1 InSphero Basic Information
10.10.2 InSphero Neurological Disease Model Chip Product Overview
10.10.3 InSphero Neurological Disease Model Chip Product Market Performance
10.10.4 InSphero Business Overview
10.10.5 InSphero Recent Developments
10.11 Hesperos
10.11.1 Hesperos Basic Information
10.11.2 Hesperos Neurological Disease Model Chip Product Overview
10.11.3 Hesperos Neurological Disease Model Chip Product Market Performance
10.11.4 Hesperos Business Overview
10.11.5 Hesperos Recent Developments
10.12 Kugelmeiers
10.12.1 Kugelmeiers Basic Information
10.12.2 Kugelmeiers Neurological Disease Model Chip Product Overview
10.12.3 Kugelmeiers Neurological Disease Model Chip Product Market Performance
10.12.4 Kugelmeiers Business Overview
10.12.5 Kugelmeiers Recent Developments
10.13 Ascendance Biotechnology
10.13.1 Ascendance Biotechnology Basic Information
10.13.2 Ascendance Biotechnology Neurological Disease Model Chip Product Overview
10.13.3 Ascendance Biotechnology Neurological Disease Model Chip Product Market Performance
10.13.4 Ascendance Biotechnology Business Overview
10.13.5 Ascendance Biotechnology Recent Developments
10.14 BioIVT
10.14.1 BioIVT Basic Information
10.14.2 BioIVT Neurological Disease Model Chip Product Overview
10.14.3 BioIVT Neurological Disease Model Chip Product Market Performance
10.14.4 BioIVT Business Overview
10.14.5 BioIVT Recent Developments
10.15 BGI Genomics
10.15.1 BGI Genomics Basic Information
10.15.2 BGI Genomics Neurological Disease Model Chip Product Overview
10.15.3 BGI Genomics Neurological Disease Model Chip Product Market Performance
10.15.4 BGI Genomics Business Overview
10.15.5 BGI Genomics Recent Developments
11 NEUROLOGICAL DISEASE MODEL CHIP MARKET FORECAST BY REGION
11.1 Global Neurological Disease Model Chip Market Size Forecast
11.2 Global Neurological Disease Model Chip Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neurological Disease Model Chip Market Size Forecast by Country
11.2.3 Asia Pacific Neurological Disease Model Chip Market Size Forecast by Region
11.2.4 South America Neurological Disease Model Chip Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neurological Disease Model Chip by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Neurological Disease Model Chip Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Neurological Disease Model Chip by Type (2026-2035)
12.1.2 Global Neurological Disease Model Chip Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Neurological Disease Model Chip by Type (2026-2035)
12.2 Global Neurological Disease Model Chip Market Forecast by Application (2026-2035)
12.2.1 Global Neurological Disease Model Chip Sales (K Units) Forecast by Application
12.2.2 Global Neurological Disease Model Chip Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neurological Disease Model Chip Market Size by Type (M USD)
Table 4. Global Neurological Disease Model Chip Market Size by Application
Table 5. Neurological Disease Model Chip Market Size Comparison by Region (M USD)
Table 6. Global Neurological Disease Model Chip Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Neurological Disease Model Chip Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neurological Disease Model Chip Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neurological Disease Model Chip Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disease Model Chip as of 2025)
Table 11. Global Market Neurological Disease Model Chip Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Neurological Disease Model Chip Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurological Disease Model Chip Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Neurological Disease Model Chip Sales by Type (K Units)
Table 27. Global Neurological Disease Model Chip Market Size by Type (M USD)
Table 28. Global Neurological Disease Model Chip Sales (K Units) by Type (2020-2025)
Table 29. Global Neurological Disease Model Chip Sales Market Share by Type (2020-2025)
Table 30. Global Neurological Disease Model Chip Market Size (M USD) by Type (2020-2025)
Table 31. Global Neurological Disease Model Chip Market Share by Type (2020-2025)
Table 32. Global Neurological Disease Model Chip Price (USD/Unit) by Type (2020-2025)
Table 33. Global Neurological Disease Model Chip Sales (K Units) by Application
Table 34. Global Neurological Disease Model Chip Market Size by Application
Table 35. Global Neurological Disease Model Chip Sales by Application (2020-2025) & (K Units)
Table 36. Global Neurological Disease Model Chip Sales Market Share by Application (2020-2025)
Table 37. Global Neurological Disease Model Chip Market Size by Application (2020-2025) & (M USD)
Table 38. Global Neurological Disease Model Chip Market Share by Application (2020-2025)
Table 39. Global Neurological Disease Model Chip Sales Growth Rate by Application (2020-2025)
Table 40. Global Neurological Disease Model Chip Sales by Region (2020-2025) & (K Units)
Table 41. Global Neurological Disease Model Chip Sales Market Share by Region (2020-2025)
Table 42. Global Neurological Disease Model Chip Market Size by Region (2020-2025) & (M USD)
Table 43. Global Neurological Disease Model Chip Market Size by Region (2020-2025)
Table 44. North America Neurological Disease Model Chip Sales by Country (2020-2025) & (K Units)
Table 45. North America Neurological Disease Model Chip Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Neurological Disease Model Chip Sales by Country (2020-2025) & (K Units)
Table 47. Europe Neurological Disease Model Chip Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Neurological Disease Model Chip Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Neurological Disease Model Chip Market Size by Region (2020-2025) & (M USD)
Table 50. South America Neurological Disease Model Chip Sales by Country (2020-2025) & (K Units)
Table 51. South America Neurological Disease Model Chip Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Neurological Disease Model Chip Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Neurological Disease Model Chip Market Size by Region (2020-2025) & (M USD)
Table 54. Global Neurological Disease Model Chip Production (K Units) by Region(2020-2025)
Table 55. Global Neurological Disease Model Chip Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Neurological Disease Model Chip Revenue Market Share by Region (2020-2025)
Table 57. Global Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Emulate Basic Information
Table 63. Emulate Neurological Disease Model Chip Product Overview
Table 64. Emulate Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Emulate Business Overview
Table 66. Emulate SWOT Analysis
Table 67. Emulate Recent Developments
Table 68. CN Bio Basic Information
Table 69. CN Bio Neurological Disease Model Chip Product Overview
Table 70. CN Bio Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. CN Bio Business Overview
Table 72. CN Bio SWOT Analysis
Table 73. CN Bio Recent Developments
Table 74. TissUse Basic Information
Table 75. TissUse Neurological Disease Model Chip Product Overview
Table 76. TissUse Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. TissUse Business Overview
Table 78. TissUse SWOT Analysis
Table 79. TissUse Recent Developments
Table 80. AxoSim Technologies Basic Information
Table 81. AxoSim Technologies Neurological Disease Model Chip Product Overview
Table 82. AxoSim Technologies Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AxoSim Technologies Business Overview
Table 84. AxoSim Technologies Recent Developments
Table 85. Nortis Basic Information
Table 86. Nortis Neurological Disease Model Chip Product Overview
Table 87. Nortis Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Nortis Business Overview
Table 89. Nortis Recent Developments
Table 90. Mimetas Basic Information
Table 91. Mimetas Neurological Disease Model Chip Product Overview
Table 92. Mimetas Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Mimetas Business Overview
Table 94. Mimetas Recent Developments
Table 95. SynVivo Basic Information
Table 96. SynVivo Neurological Disease Model Chip Product Overview
Table 97. SynVivo Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. SynVivo Business Overview
Table 99. SynVivo Recent Developments
Table 100. Axion Biosystems Basic Information
Table 101. Axion Biosystems Neurological Disease Model Chip Product Overview
Table 102. Axion Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Axion Biosystems Business Overview
Table 104. Axion Biosystems Recent Developments
Table 105. Tara Biosystems Basic Information
Table 106. Tara Biosystems Neurological Disease Model Chip Product Overview
Table 107. Tara Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Tara Biosystems Business Overview
Table 109. Tara Biosystems Recent Developments
Table 110. InSphero Basic Information
Table 111. InSphero Neurological Disease Model Chip Product Overview
Table 112. InSphero Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. InSphero Business Overview
Table 114. InSphero Recent Developments
Table 115. Hesperos Basic Information
Table 116. Hesperos Neurological Disease Model Chip Product Overview
Table 117. Hesperos Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Hesperos Business Overview
Table 119. Hesperos Recent Developments
Table 120. Kugelmeiers Basic Information
Table 121. Kugelmeiers Neurological Disease Model Chip Product Overview
Table 122. Kugelmeiers Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Kugelmeiers Business Overview
Table 124. Kugelmeiers Recent Developments
Table 125. Ascendance Biotechnology Basic Information
Table 126. Ascendance Biotechnology Neurological Disease Model Chip Product Overview
Table 127. Ascendance Biotechnology Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Ascendance Biotechnology Business Overview
Table 129. Ascendance Biotechnology Recent Developments
Table 130. BioIVT Basic Information
Table 131. BioIVT Neurological Disease Model Chip Product Overview
Table 132. BioIVT Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. BioIVT Business Overview
Table 134. BioIVT Recent Developments
Table 135. BGI Genomics Basic Information
Table 136. BGI Genomics Neurological Disease Model Chip Product Overview
Table 137. BGI Genomics Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. BGI Genomics Business Overview
Table 139. BGI Genomics Recent Developments
Table 140. Global Neurological Disease Model Chip Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Neurological Disease Model Chip Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Neurological Disease Model Chip Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Neurological Disease Model Chip Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Neurological Disease Model Chip Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Neurological Disease Model Chip Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Neurological Disease Model Chip Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Neurological Disease Model Chip Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Neurological Disease Model Chip Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Neurological Disease Model Chip Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Neurological Disease Model Chip Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Neurological Disease Model Chip Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Neurological Disease Model Chip Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Neurological Disease Model Chip Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Neurological Disease Model Chip Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Neurological Disease Model Chip Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Neurological Disease Model Chip Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neurological Disease Model Chip Market Size by Type (M USD)
Table 4. Global Neurological Disease Model Chip Market Size by Application
Table 5. Neurological Disease Model Chip Market Size Comparison by Region (M USD)
Table 6. Global Neurological Disease Model Chip Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Neurological Disease Model Chip Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neurological Disease Model Chip Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neurological Disease Model Chip Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disease Model Chip as of 2025)
Table 11. Global Market Neurological Disease Model Chip Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Neurological Disease Model Chip Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurological Disease Model Chip Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Neurological Disease Model Chip Sales by Type (K Units)
Table 27. Global Neurological Disease Model Chip Market Size by Type (M USD)
Table 28. Global Neurological Disease Model Chip Sales (K Units) by Type (2020-2025)
Table 29. Global Neurological Disease Model Chip Sales Market Share by Type (2020-2025)
Table 30. Global Neurological Disease Model Chip Market Size (M USD) by Type (2020-2025)
Table 31. Global Neurological Disease Model Chip Market Share by Type (2020-2025)
Table 32. Global Neurological Disease Model Chip Price (USD/Unit) by Type (2020-2025)
Table 33. Global Neurological Disease Model Chip Sales (K Units) by Application
Table 34. Global Neurological Disease Model Chip Market Size by Application
Table 35. Global Neurological Disease Model Chip Sales by Application (2020-2025) & (K Units)
Table 36. Global Neurological Disease Model Chip Sales Market Share by Application (2020-2025)
Table 37. Global Neurological Disease Model Chip Market Size by Application (2020-2025) & (M USD)
Table 38. Global Neurological Disease Model Chip Market Share by Application (2020-2025)
Table 39. Global Neurological Disease Model Chip Sales Growth Rate by Application (2020-2025)
Table 40. Global Neurological Disease Model Chip Sales by Region (2020-2025) & (K Units)
Table 41. Global Neurological Disease Model Chip Sales Market Share by Region (2020-2025)
Table 42. Global Neurological Disease Model Chip Market Size by Region (2020-2025) & (M USD)
Table 43. Global Neurological Disease Model Chip Market Size by Region (2020-2025)
Table 44. North America Neurological Disease Model Chip Sales by Country (2020-2025) & (K Units)
Table 45. North America Neurological Disease Model Chip Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Neurological Disease Model Chip Sales by Country (2020-2025) & (K Units)
Table 47. Europe Neurological Disease Model Chip Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Neurological Disease Model Chip Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Neurological Disease Model Chip Market Size by Region (2020-2025) & (M USD)
Table 50. South America Neurological Disease Model Chip Sales by Country (2020-2025) & (K Units)
Table 51. South America Neurological Disease Model Chip Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Neurological Disease Model Chip Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Neurological Disease Model Chip Market Size by Region (2020-2025) & (M USD)
Table 54. Global Neurological Disease Model Chip Production (K Units) by Region(2020-2025)
Table 55. Global Neurological Disease Model Chip Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Neurological Disease Model Chip Revenue Market Share by Region (2020-2025)
Table 57. Global Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Neurological Disease Model Chip Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Emulate Basic Information
Table 63. Emulate Neurological Disease Model Chip Product Overview
Table 64. Emulate Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Emulate Business Overview
Table 66. Emulate SWOT Analysis
Table 67. Emulate Recent Developments
Table 68. CN Bio Basic Information
Table 69. CN Bio Neurological Disease Model Chip Product Overview
Table 70. CN Bio Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. CN Bio Business Overview
Table 72. CN Bio SWOT Analysis
Table 73. CN Bio Recent Developments
Table 74. TissUse Basic Information
Table 75. TissUse Neurological Disease Model Chip Product Overview
Table 76. TissUse Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. TissUse Business Overview
Table 78. TissUse SWOT Analysis
Table 79. TissUse Recent Developments
Table 80. AxoSim Technologies Basic Information
Table 81. AxoSim Technologies Neurological Disease Model Chip Product Overview
Table 82. AxoSim Technologies Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AxoSim Technologies Business Overview
Table 84. AxoSim Technologies Recent Developments
Table 85. Nortis Basic Information
Table 86. Nortis Neurological Disease Model Chip Product Overview
Table 87. Nortis Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Nortis Business Overview
Table 89. Nortis Recent Developments
Table 90. Mimetas Basic Information
Table 91. Mimetas Neurological Disease Model Chip Product Overview
Table 92. Mimetas Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Mimetas Business Overview
Table 94. Mimetas Recent Developments
Table 95. SynVivo Basic Information
Table 96. SynVivo Neurological Disease Model Chip Product Overview
Table 97. SynVivo Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. SynVivo Business Overview
Table 99. SynVivo Recent Developments
Table 100. Axion Biosystems Basic Information
Table 101. Axion Biosystems Neurological Disease Model Chip Product Overview
Table 102. Axion Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Axion Biosystems Business Overview
Table 104. Axion Biosystems Recent Developments
Table 105. Tara Biosystems Basic Information
Table 106. Tara Biosystems Neurological Disease Model Chip Product Overview
Table 107. Tara Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Tara Biosystems Business Overview
Table 109. Tara Biosystems Recent Developments
Table 110. InSphero Basic Information
Table 111. InSphero Neurological Disease Model Chip Product Overview
Table 112. InSphero Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. InSphero Business Overview
Table 114. InSphero Recent Developments
Table 115. Hesperos Basic Information
Table 116. Hesperos Neurological Disease Model Chip Product Overview
Table 117. Hesperos Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Hesperos Business Overview
Table 119. Hesperos Recent Developments
Table 120. Kugelmeiers Basic Information
Table 121. Kugelmeiers Neurological Disease Model Chip Product Overview
Table 122. Kugelmeiers Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Kugelmeiers Business Overview
Table 124. Kugelmeiers Recent Developments
Table 125. Ascendance Biotechnology Basic Information
Table 126. Ascendance Biotechnology Neurological Disease Model Chip Product Overview
Table 127. Ascendance Biotechnology Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Ascendance Biotechnology Business Overview
Table 129. Ascendance Biotechnology Recent Developments
Table 130. BioIVT Basic Information
Table 131. BioIVT Neurological Disease Model Chip Product Overview
Table 132. BioIVT Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. BioIVT Business Overview
Table 134. BioIVT Recent Developments
Table 135. BGI Genomics Basic Information
Table 136. BGI Genomics Neurological Disease Model Chip Product Overview
Table 137. BGI Genomics Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. BGI Genomics Business Overview
Table 139. BGI Genomics Recent Developments
Table 140. Global Neurological Disease Model Chip Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Neurological Disease Model Chip Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Neurological Disease Model Chip Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Neurological Disease Model Chip Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Neurological Disease Model Chip Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Neurological Disease Model Chip Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Neurological Disease Model Chip Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Neurological Disease Model Chip Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Neurological Disease Model Chip Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Neurological Disease Model Chip Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Neurological Disease Model Chip Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Neurological Disease Model Chip Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Neurological Disease Model Chip Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Neurological Disease Model Chip Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Neurological Disease Model Chip Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Neurological Disease Model Chip Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Neurological Disease Model Chip Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neurological Disease Model Chip
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurological Disease Model Chip Market Size (M USD), 2025-2035
Figure 5. Global Neurological Disease Model Chip Market Size (M USD) (2020-2035)
Figure 6. Global Neurological Disease Model Chip Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurological Disease Model Chip Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neurological Disease Model Chip Product Life Cycle
Figure 13. Neurological Disease Model Chip Sales Share by Manufacturers in 2025
Figure 14. Global Neurological Disease Model Chip Revenue Share by Manufacturers in 2025
Figure 15. Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Neurological Disease Model Chip Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neurological Disease Model Chip Revenue in 2025
Figure 18. Industry Chain Map of Neurological Disease Model Chip
Figure 19. Global Neurological Disease Model Chip Market PEST Analysis
Figure 20. Global Neurological Disease Model Chip Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neurological Disease Model Chip Market Share by Type
Figure 27. Sales Market Share of Neurological Disease Model Chip by Type (2020-2025)
Figure 28. Sales Market Share of Neurological Disease Model Chip by Type in 2025
Figure 29. Market Share of Neurological Disease Model Chip by Type (2020-2025)
Figure 30. Market Share of Neurological Disease Model Chip by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neurological Disease Model Chip Market Share by Application
Figure 33. Global Neurological Disease Model Chip Sales Market Share by Application (2020-2025)
Figure 34. Global Neurological Disease Model Chip Sales Market Share by Application in 2025
Figure 35. Global Neurological Disease Model Chip Market Share by Application (2020-2025)
Figure 36. Global Neurological Disease Model Chip Market Share by Application in 2025
Figure 37. Global Neurological Disease Model Chip Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neurological Disease Model Chip Sales Market Share by Region (2020-2025)
Figure 39. Global Neurological Disease Model Chip Market Size by Region (2020-2025)
Figure 40. North America Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Neurological Disease Model Chip Sales Market Share by Country in 2024
Figure 43. North America Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neurological Disease Model Chip Market Size by Country in 2024
Figure 45. U.S. Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neurological Disease Model Chip Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Neurological Disease Model Chip Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neurological Disease Model Chip Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neurological Disease Model Chip Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Neurological Disease Model Chip Sales Market Share by Country in 2024
Figure 53. Europe Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neurological Disease Model Chip Market Size by Country in 2024
Figure 55. Germany Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Neurological Disease Model Chip Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neurological Disease Model Chip Market Size by Region in 2024
Figure 68. China Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 79. South America Neurological Disease Model Chip Sales Market Share by Country in 2024
Figure 80. South America Neurological Disease Model Chip Market Size and Growth Rate (M USD)
Figure 81. South America Neurological Disease Model Chip Market Size by Country in 2024
Figure 82. Brazil Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Neurological Disease Model Chip Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neurological Disease Model Chip Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neurological Disease Model Chip Market Size by Region in 2024
Figure 92. Saudi Arabia Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neurological Disease Model Chip Production Market Share by Region (2020-2025)
Figure 103. North America Neurological Disease Model Chip Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Neurological Disease Model Chip Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Neurological Disease Model Chip Production (K Units) Growth Rate (2020-2025)
Figure 106. China Neurological Disease Model Chip Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Neurological Disease Model Chip Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Neurological Disease Model Chip Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Neurological Disease Model Chip Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Neurological Disease Model Chip Market Share Forecast by Type (2026-2035)
Figure 111. Global Neurological Disease Model Chip Sales Forecast by Application (2026-2035)
Figure 112. Global Neurological Disease Model Chip Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Neurological Disease Model Chip
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurological Disease Model Chip Market Size (M USD), 2025-2035
Figure 5. Global Neurological Disease Model Chip Market Size (M USD) (2020-2035)
Figure 6. Global Neurological Disease Model Chip Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurological Disease Model Chip Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neurological Disease Model Chip Product Life Cycle
Figure 13. Neurological Disease Model Chip Sales Share by Manufacturers in 2025
Figure 14. Global Neurological Disease Model Chip Revenue Share by Manufacturers in 2025
Figure 15. Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Neurological Disease Model Chip Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neurological Disease Model Chip Revenue in 2025
Figure 18. Industry Chain Map of Neurological Disease Model Chip
Figure 19. Global Neurological Disease Model Chip Market PEST Analysis
Figure 20. Global Neurological Disease Model Chip Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neurological Disease Model Chip Market Share by Type
Figure 27. Sales Market Share of Neurological Disease Model Chip by Type (2020-2025)
Figure 28. Sales Market Share of Neurological Disease Model Chip by Type in 2025
Figure 29. Market Share of Neurological Disease Model Chip by Type (2020-2025)
Figure 30. Market Share of Neurological Disease Model Chip by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neurological Disease Model Chip Market Share by Application
Figure 33. Global Neurological Disease Model Chip Sales Market Share by Application (2020-2025)
Figure 34. Global Neurological Disease Model Chip Sales Market Share by Application in 2025
Figure 35. Global Neurological Disease Model Chip Market Share by Application (2020-2025)
Figure 36. Global Neurological Disease Model Chip Market Share by Application in 2025
Figure 37. Global Neurological Disease Model Chip Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neurological Disease Model Chip Sales Market Share by Region (2020-2025)
Figure 39. Global Neurological Disease Model Chip Market Size by Region (2020-2025)
Figure 40. North America Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Neurological Disease Model Chip Sales Market Share by Country in 2024
Figure 43. North America Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neurological Disease Model Chip Market Size by Country in 2024
Figure 45. U.S. Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neurological Disease Model Chip Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Neurological Disease Model Chip Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neurological Disease Model Chip Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neurological Disease Model Chip Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Neurological Disease Model Chip Sales Market Share by Country in 2024
Figure 53. Europe Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neurological Disease Model Chip Market Size by Country in 2024
Figure 55. Germany Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Neurological Disease Model Chip Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neurological Disease Model Chip Market Size by Region in 2024
Figure 68. China Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 79. South America Neurological Disease Model Chip Sales Market Share by Country in 2024
Figure 80. South America Neurological Disease Model Chip Market Size and Growth Rate (M USD)
Figure 81. South America Neurological Disease Model Chip Market Size by Country in 2024
Figure 82. Brazil Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Neurological Disease Model Chip Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neurological Disease Model Chip Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neurological Disease Model Chip Market Size by Region in 2024
Figure 92. Saudi Arabia Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neurological Disease Model Chip Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Neurological Disease Model Chip Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neurological Disease Model Chip Production Market Share by Region (2020-2025)
Figure 103. North America Neurological Disease Model Chip Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Neurological Disease Model Chip Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Neurological Disease Model Chip Production (K Units) Growth Rate (2020-2025)
Figure 106. China Neurological Disease Model Chip Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Neurological Disease Model Chip Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Neurological Disease Model Chip Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Neurological Disease Model Chip Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Neurological Disease Model Chip Market Share Forecast by Type (2026-2035)
Figure 111. Global Neurological Disease Model Chip Sales Forecast by Application (2026-2035)
Figure 112. Global Neurological Disease Model Chip Market Share Forecast by Application (2026-2035)
